Medicines from microbiota

Nature Biotechnology

Volumn 31, Issue 4, 2013, Pages 309-315

  Olle, Bernat ^a  

^a Vedanta Biosciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME RNA;

ANTIBIOTIC ASSOCIATED DIARRHEA; ARTICLE; BACTERIAL GROWTH; BACTEROIDES THETAIOTAOMICRON; CLOSTRIDIUM DIFFICILE; DIET; ENTERITIS; GASTROENTEROLOGY; HIGH THROUGHPUT SEQUENCING; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPEROXALURIA; ILEITIS; IMMUNOLOGY; INFECTION; IRRITABLE COLON; LACTOBACILLUS CRISPATUS; LACTOBACILLUS RHAMNOSUS; METABOLIC DISORDER; MICROBIAL COMMUNITY; MICROFLORA; MUCOSA INFLAMMATION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; URINARY TRACT INFECTION; VAGINITIS;

ANIMALS; BIOLOGICAL THERAPY; DRUG DISCOVERY; HUMANS; METAGENOME; PATENTS AS TOPIC; PHARMACEUTICAL PREPARATIONS; RESEARCH SUPPORT AS TOPIC;

EID: 84877249773     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2548     Document Type: Article

References (20)

1. Blumberg, R. & Powrie, F. Microbiota, disease, and back to health: a metastable journey. Sci. Transl. Med. 4, 137rv7 (2012).
2. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbi-ome. Nature 486, 207-214 (2012).
3. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
4. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
5. Papa, E. et al. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowl syndrome. PLoS ONE 7, e39242 (2012).
6. van Nood, E. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415 (2013).
7. Eckburg, P.B. et al. Diversity of the human intestinal flora. Science 308, 1635-1638 (2005).
8. Turnbaugh, P.J. et al. An obesity-associated gut micro-biome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006).
9. Rakoff-Nahoum, S. et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
10. Woese, C.R. et al. Phylogenetic structure of the prokary-otic domain: the primary kingdoms. Proc. Natl. Acad. Sci. USA 74, 5088-5090 (1977).
11. Khoruts, A. et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 44, 354-360 (2010).
12. Britton, R.A. et al. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20, 313-319 (2012).
13. Gough, E. et al. Systematic review of intestinal micro-biota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994-1002 (2011).
14. Kachrimanidou, M. et al. Clostridium difficile infection: a comprehensive review. Crit. Rev. Microbiol. 37, 178-187 (2011).
15. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
16. Lawley, T.D. et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995 (2012).
17. Yan, F. et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575 (2007).
18. Dethlefsen, L. et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rRNA sequencing. PLoS Biology, 6 (11), 2008. doi:10.1371/journal.pbio.0060280
19. Tannock, G.W. et al. A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology 156, 3354-3359 (2010).
20. Kuczynski, J. et al. Experimental and analytical tools for studying the human microbiome. Nat. Rev. Genet. 13, 47-58 (2012).